Virologists are experts who study viruses—microscopic agents that can invade living cells and cause a wide range of health conditions in humans, animals, and plants. These specialists play a central role in identifying new viral strains, understanding how they spread, and determining how they interact with the immune system. In clinical laboratories, they analyze blood, tissue, and other biological samples to detect viral infections and provide vital information that guides treatment. Their work is especially critical during outbreaks when rapid identification of the causative agent is essential to contain transmission and reduce impact. They are often the first responders in laboratory settings when novel viruses emerge.
Virologists are instrumental in advancing vaccine research, antiviral drug development, and public health preparedness. They collaborate with epidemiologists, clinicians, and policymakers to monitor viral trends and respond to global health threats. Their research often includes exploring how viruses evolve, mutate, and develop resistance to treatments. This knowledge enables the creation of more effective therapeutic and preventive strategies. From combating seasonal illnesses to addressing global pandemics, their insights are key to protecting public health. As viral threats continue to emerge and re-emerge, these scientists remain at the forefront of medical innovation and disease prevention, offering expertise that is both timely and transformative.
 
                                 
                                 
                                 
                                 
                                 
                                 
                             
                             
                             
                            
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Mathematical modeling of COVID-19 dynamics in a West African context
Christabel Emaeyak James, University of Glasgow, United Kingdom
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan